Healthcare provider profile · identity verified

James Alexander Mclean, M.D.

Family Practice · PORT CLINTON, OH · NPI 1518050152

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	437	112
Amlodipine Besylate	Amlodipine Besylate	282	73
Lisinopril	Lisinopril	282	76
Omeprazole	Omeprazole	250	64
Levothyroxine Sodium	Levothyroxine Sodium	221	42
Metoprolol Succinate	Metoprolol Succinate	216	49
Hydrochlorothiazide	Hydrochlorothiazide	206	50
Eliquis	Apixaban	202	26
Furosemide	Furosemide	188	38
Potassium Chloride	Potassium Chloride	168	42
Losartan Potassium	Losartan Potassium	160	42
Tamsulosin Hcl	Tamsulosin Hcl	151	30
Metformin Hcl	Metformin Hcl	134	32
Metoprolol Tartrate	Metoprolol Tartrate	125	35
Escitalopram Oxalate	Escitalopram Oxalate	124	23
Carvedilol	Carvedilol	122	23
Gabapentin	Gabapentin	101	29
Prednisone	Prednisone	98	57
Pantoprazole Sodium	Pantoprazole Sodium	94	21
Simvastatin	Simvastatin	94	26
Oxybutynin Chloride Er	Oxybutynin Chloride	91	15
Pravastatin Sodium	Pravastatin Sodium	88	22
Albuterol Sulfate Hfa	Albuterol Sulfate	85	29
Duloxetine Hcl	Duloxetine Hcl	79	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	79	15
Lorazepam	Lorazepam	74	19
Warfarin Sodium	Warfarin Sodium	74	11
Glimepiride	Glimepiride	73	18
Venlafaxine Hcl Er	Venlafaxine Hcl	73	12
Ozempic	Semaglutide	70	suppressed
Citalopram Hbr	Citalopram Hydrobromide	69	16
Clopidogrel	Clopidogrel Bisulfate	65	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	12
Farxiga	Dapagliflozin Propanediol	62	11
Fluoxetine Hcl	Fluoxetine Hcl	60	suppressed
Trazodone Hcl	Trazodone Hcl	58	12
Bupropion Xl	Bupropion Hcl	56	11
Celecoxib	Celecoxib	55	14
Bumetanide	Bumetanide	54	12
Alprazolam	Alprazolam	48	18
Sertraline Hcl	Sertraline Hcl	48	11
Baclofen	Baclofen	47	suppressed
Januvia	Sitagliptin Phosphate	47	suppressed
Meloxicam	Meloxicam	47	16
Memantine Hcl	Memantine Hcl	47	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	46	14
Ezetimibe	Ezetimibe	42	suppressed
Allopurinol	Allopurinol	40	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	12
Atenolol	Atenolol	35	11
Nystatin	Nystatin	35	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Clonazepam	Clonazepam	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Tramadol Hcl	Tramadol Hcl	32	15
Finasteride	Finasteride	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Cephalexin	Cephalexin	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	suppressed
Famotidine	Famotidine	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Sotalol	Sotalol Hcl	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Nitroglycerin	Nitroglycerin	22	17
Jardiance	Empagliflozin	21	suppressed
Primidone	Primidone	21	suppressed
Albuterol Sulfate	Albuterol Sulfate	20	suppressed
Amoxicillin	Amoxicillin	20	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	15
Glipizide	Glipizide	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Azithromycin	Azithromycin	17	11
Betamethasone Valerate	Betamethasone Valerate	17	suppressed
Cimetidine	Cimetidine	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Repatha Syringe	Evolocumab	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	11
Midodrine Hcl	Midodrine Hcl	14	suppressed
Nitroglycerin Patch	Nitroglycerin	14	suppressed
Topiramate	Topiramate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Methimazole	Methimazole	11	suppressed
Pulmicort Flexhaler	Budesonide	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error